Skip to search.
 TSX Up 0.15% TSX Ventures Down 0.75%

Novartis AG (NVS)

-NYSE
103.57 Down 0.79(0.76%) 4:02PM EDT
Add to Portfolio
Prev Close:104.36
Open:104.17
Bid:103.54 x 800
Ask:103.55 x 400
1y Target Est:113.50
Beta:0.62
Next Earnings Date:N/A
Day's Range:103.32 - 104.28
52wk Range:84.17 - 106.84
Volume:2,087,856
Avg Vol (3m):1,593,240
Market Cap:250.14B
P/E (ttm):13.02
EPS (ttm):7.96
Div & Yield:2.67 (2.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVSDown 0.76%250.14B
MRKDown 0.59%165.84B
PFEDown 0.11%222.35B
SNYUp 0.02%139.87B

Key Statistics

Forward P/E (1 yr):19.04
P/S (ttm):4.87
Ex-Dividend Date:02-Mar-15

Analysts

Annual EPS Est (Dec-15) :5.15
Quarterly EPS Est (Sep-15) :1.34
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):3.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback